DL-001, a novel rapamycin analogue with highly selective mTORC1 inhibitor activity in vivo Sep. 26, 2019 No Comments
Identification of a novel Mtb inhibitor BRD-8000.3 through large-scale chemical-genetics platform Sep. 19, 2019 No Comments
Novel oxyntomodulin analogue OXM-001 reduces body weight and improves glucose tolerance Sep. 18, 2019 No Comments
Discovery of a selective OX1 receptor antagonist for substance abuse and dependency Sep. 5, 2019 No Comments
JMJD6 predicts poor prognosis in ovarian cancer and can be a new therapeutic target Sep. 5, 2019 No Comments
Targeted protein degradation with DGY-08-097 shows promise for hepatitis C virus treatment Sep. 4, 2019 No Comments
TLR4 agonist INI-2004 as immunostimulant for the treatment of infectious diseases Sep. 2, 2019 No Comments
RSS